See more : Welltower Inc. (WELL) Income Statement Analysis – Financial Results
Complete financial analysis of Nichi-Iko Pharmaceutical Co., Ltd. (NHKFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nichi-Iko Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Swiss Steel Holding AG (0QPH.L) Income Statement Analysis – Financial Results
- Kopy Goldfields AB (publ) (KOPY.ST) Income Statement Analysis – Financial Results
- eBay Inc. (EBAY) Income Statement Analysis – Financial Results
- Indo Amines Limited (INDOAMIN.NS) Income Statement Analysis – Financial Results
- Global Health Clinics Ltd. (MJRX.CN) Income Statement Analysis – Financial Results
Nichi-Iko Pharmaceutical Co., Ltd. (NHKFF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.nichiiko.co.jp
About Nichi-Iko Pharmaceutical Co., Ltd.
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.
Source: https://incomestatements.info
Category: Stock Reports